FDA Import Refusal AEK-9482743-0/21/1 — Celltrion Inc.
The FDA refused shipment AEK-9482743-0/21/1 from Celltrion Inc. (South Korea) on July 30, 2021. The refused product falls under Drugs and Biologics — DILTIAZEM MALATE (ANTI-HYPERTENSIVE - PART II). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal Details
- Date
- July 30, 2021
- Country
- South Korea
- Product Category
- Drugs and Biologics
- Product Code
- 62ODY25 DILTIAZEM MALATE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 75